ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo +38 more
wiley +1 more source
Hereditary Hyperferritinemia-Cataract Syndrome Misdiagnosed as Iron Overload: A Case Report. [PDF]
Güven S, Öztürk M.
europepmc +1 more source
Too drained to help? How work overload fuels psychological strain and why proactive personality functions as a buffer. [PDF]
Wei Z, Wang J, Gao Q.
europepmc +1 more source
Intestine-Specific Ferroportin Ablation Rescues from Systemic Iron Overload in Mice. [PDF]
Castillo C, Gim S, Das NK.
europepmc +1 more source
Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI. [PDF]
Goldenberg M +9 more
europepmc +1 more source
JP2 and JCN Crosstalk Abrogate MURF1-Mediated JCN Ubiquitination and Degradation in Cardiomyocytes. [PDF]
Ji X +13 more
europepmc +1 more source
Moderating effect of social support in the relationship between perceived work overload and patient safety behaviours among nursing interns in Nigeria. [PDF]
Balogun AG, Onyencho VC, Oduaran CA.
europepmc +1 more source
Operator Overloading as an Enabling Technology for Automatic Differentiation
George F. Corliss, Andreas Griewank
openalex +1 more source

